<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75340</article-id><article-id pub-id-type="doi">10.7554/eLife.75340</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-259939"><name><surname>Gong</surname><given-names>Bo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2763-6829</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291867"><name><surname>Zhong</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291866"><name><surname>Hao</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262559"><name><surname>Zhang</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262560"><name><surname>Jiang</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262561"><name><surname>Li</surname><given-names>Huan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262562"><name><surname>Xiao</surname><given-names>Jialing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262563"><name><surname>Li</surname><given-names>Chenglong</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262564"><name><surname>Luo</surname><given-names>Lan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262565"><name><surname>Shuai</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262566"><name><surname>Wang</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262567"><name><surname>Liu</surname><given-names>Yuping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262569"><name><surname>Shi</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-262570"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Health Management</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line><named-content content-type="city">ChengDu</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">Department of Orthopaedics</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line><named-content content-type="city">ChengDu</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Hematology</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line><named-content content-type="city">ChengDu</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution>Chengdu University of Traditional Chinese Medicine</institution>, <addr-line><named-content content-type="city">Chengdu</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-263212"><name><surname>Liang</surname><given-names>Yang</given-names></name><role>Reviewing editor</role><aff><institution>Sun Yat-sen University Cancer Center</institution>, <country>China</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gongbo2007@hotmail.com</email> (BG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>zhangwspine@163.com</email> (WZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>10</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e75340</elocation-id><history><date date-type="received"><day>07</day><month>11</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Gong et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Gong et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75340-v1.pdf"/><abstract><p>Multiple myeloma (MM) accounts for ~10% of all haematologic malignancies. Little is known about high intratumour heterogeneities in patients stratified by the Revised International Staging System (R-ISS). Herein, we constructed a single-cell transcriptome atlas to compare differential expression patterns among stages. We found that a novel cytotoxic plasma cell (PC) population exhibited with NKG7 positive was obviously enriched in stage II patients. Additionally, a malignant plasma cell population with significantly elevated expression of MKI67 and PCNA was associated with unfavourable prognosis and Epstein-Barr virus (EBV) infection in our collected samples. Moreover, Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) was found and verified to promote proliferation of MM cell lines, suggesting RRM2 may serve as a detrimental marker in MM. The percentages of CD8<sup>+</sup> T cells and NKT cells decreased along with R-ISS stages, reflecting the plasticity of the tumour immune microenvironment. Importantly, their crosstalks with myeloid cells and PC identified several potential immunotargets such as SIRPA-CD47, and CD74-MIF, respectively. Collectively, this study provided an R-ISS-related single-cell MM atlas and revealed the clinical significance of novel PC clusters, as well as potential immunotargets in MM progression.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>Youth Funds,82002212</award-id><principal-award-recipient><name><surname>Zhong</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Science &amp; Technology Department of Sichuan Province</institution></institution-wrap></funding-source><award-id>Applied Basic Research,2022YFS0100</award-id><principal-award-recipient><name><surname>Hao</surname><given-names>Peng</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010822</institution-id><institution>Chengdu Science and Technology Bureau</institution></institution-wrap></funding-source><award-id>Applied Basic Research,2019-YF05-00572-SN</award-id><principal-award-recipient><name><surname>Zhong</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source><award-id>general program&amp;#xFF0C;2019M663567</award-id><principal-award-recipient><name><surname>Zhong</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>UESTC</institution></institution-wrap></funding-source><award-id>Basic scientific research,ZYGX2020J024</award-id><principal-award-recipient><name><surname>Zhong</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>UESTC</institution></institution-wrap></funding-source><award-id>Medicine-engineering interdisciplinary,ZYGX2021YGLH006</award-id><principal-award-recipient><name><surname>Zhong</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Science &amp;Technology Department of Sichuan Province</institution></institution-wrap></funding-source><award-id>Outstanding Youth Fund&amp;#xFF0C;2022JDTD0024</award-id><principal-award-recipient><name><surname>Gong</surname><given-names>Bo</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010822</institution-id><institution>Chengdu Science and Technology Bureau</institution></institution-wrap></funding-source><award-id>Applied Basic Research,2022-YF05-01625-SN</award-id><principal-award-recipient><name><surname>Gong</surname><given-names>Bo</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Sichuan cadre health care project</institution></institution-wrap></funding-source><award-id>Sichuan cadre health care project,2022-216</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution>UESTC</institution></institution-wrap></funding-source><award-id>Medicine-engineering interdisciplinary,ZYGX2021YGLH204</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><funding-statement>The roles of the funders were to do single cell sequence, analysis data, and verify the conclusions.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Written informed consents were obtained from all subjects. All experimental procedures were approved by the Medical ethics committee of Sichuan Provincial People's Hospital and carried out in accordance with the principles of the Declaration of Helsinki. ALL of the patients signed the informed consent containing contact Information, the purpose of the study, risks and benefits from this study, consent to publish the manuscript. The protocol numbers was 2020-240.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE176131.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhong L</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>Identification of heterogeneous networks and plasma-monocytes crosstalks in multiple myeloma stratified by R-ISS system through single-cell sequencing</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE176131">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE176131</ext-link><comment>NCBI Gene Expression Omnibus, GSE176131</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Chng WJ</collab><collab>Huang GF</collab><collab>Chung TH</collab><collab>Ng SB et al</collab></person-group><year iso-8601-date="2011">2011</year><source>Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE6477">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE6477</ext-link><comment>NCBI Gene Expression Omnibus, GSE6477</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ledergor G</collab><collab>Weiner A</collab><collab>Zada M</collab><collab>Wang SY et al.</collab></person-group><year iso-8601-date="2018">2018</year><source>Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma.</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117156">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117156</ext-link><comment>NCBI Gene Expression Omnibus, GSE117156</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-75340-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>